gabapentin has been researched along with Brain Diseases in 5 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To inform their safe prescribing in older adults with chronic kidney disease (CKD), we examined the 30-day risk of serious adverse events according to the prescribed starting dose." | 1.72 | Higher-Dose Gabapentinoids and the Risk of Adverse Events in Older Adults With CKD: A Population-Based Cohort Study. ( Ahmadi, F; Blake, PG; Cowan, A; Fleet, JL; Garg, AX; Muanda, FT; Sontrop, JM; Weir, MA, 2022) |
| "Gabapentin was administered by a nasogastric tube that quickly resulted in a reversal of his symptoms." | 1.51 | Complex encephalopathy arising from the combination of opioids and gabapentin. ( Handa, R; Kak, V; Singh, H; Wasilewski, A, 2019) |
| "Gabapentin was administered by a nasogastric tube that quickly resulted in a reversal of his symptoms." | 1.51 | Complex encephalopathy arising from the combination of opioids and gabapentin. ( Handa, R; Kak, V; Singh, H; Wasilewski, A, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muanda, FT | 1 |
| Weir, MA | 1 |
| Ahmadi, F | 1 |
| Sontrop, JM | 1 |
| Cowan, A | 1 |
| Fleet, JL | 1 |
| Blake, PG | 1 |
| Garg, AX | 1 |
| Spiegel, J | 1 |
| Collins, B | 1 |
| Singh, H | 2 |
| Handa, R | 2 |
| Kak, V | 2 |
| Wasilewski, A | 2 |
| Sechi, G | 1 |
| Murgia, B | 1 |
| Sau, G | 1 |
| Peddone, L | 1 |
| Tirotto, A | 1 |
| Barrocu, M | 1 |
| Rosati, G | 1 |
5 other studies available for gabapentin and Brain Diseases
| Article | Year |
|---|---|
Higher-Dose Gabapentinoids and the Risk of Adverse Events in Older Adults With CKD: A Population-Based Cohort Study.
Topics: Aged; Aged, 80 and over; Brain Diseases; Cohort Studies; Female; Gabapentin; Humans; Male; Ontario; | 2022 |
Hyperglycemia and Hypoglycemia-Related Chorea in an 83-Year-Old Man.
Topics: Aged, 80 and over; Brain Diseases; Chorea; Gabapentin; Humans; Hyperglycemia; Hypoglycemia; Hypoglyc | 2022 |
Complex encephalopathy arising from the combination of opioids and gabapentin.
Topics: Analgesics, Opioid; Brain Diseases; Chronic Pain; Gabapentin; Humans; Male; Middle Aged; Morphine; R | 2019 |
Complex encephalopathy arising from the combination of opioids and gabapentin.
Topics: Analgesics; Analgesics, Opioid; Brain Diseases; Drug Interactions; Gabapentin; Humans; Male; Middle | 2019 |
Asterixis and toxic encephalopathy induced by gabapentin.
Topics: Acetates; Aged; Amines; Anticonvulsants; Brain; Brain Diseases; Carbamazepine; Cyclohexanecarboxylic | 2004 |